ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

French Maritime Pine Bark Extract

Also known as: French maritime pine bark extract, Pycnogenol®, Pinus pinaster Ait. ssp. Atlantica Extract

Overview

French maritime pine bark extract, derived from *Pinus pinaster Ait. ssp. Atlantica*, is a polyphenol-rich supplement standardized to contain 70 ± 5% procyanidins. Primarily sourced from southwest France, it is extensively researched for its potential benefits in cardiovascular health, chronic venous insufficiency, cognitive function, and more. The extract is rich in procyanidins, catechin, epicatechin, taxifolin, and phenolic acids. With over 450 published studies and 160 human clinical trials, the extract has demonstrated anti-inflammatory, antioxidant, and endothelial-protective effects. It is considered a well-researched supplement with high-quality evidence supporting its various health applications. It is available in capsule or tablet form and is generally considered safe with minimal side effects.

Benefits

French maritime pine bark extract offers several evidence-based benefits. It improves endothelial function, reduces blood pressure, and prevents platelet aggregation, supporting cardiovascular health. Clinical studies confirm its effectiveness in treating chronic venous insufficiency by improving venous function and reducing symptoms. Emerging research suggests cognitive benefits, particularly in attention and memory. Its anti-inflammatory and antioxidant properties protect against oxidative stress and UV-radiation-induced erythema. It may also alleviate premenstrual symptoms and climacteric syndrome symptoms in perimenopausal women. While effect sizes vary, significant improvements have been observed across various health domains, typically within a few weeks to months of consistent use. Further research is ongoing to explore its full potential.

How it works

French maritime pine bark extract exerts its effects through multiple biological pathways. As a potent antioxidant, it scavenges free radicals, enhances the synthesis of anti-oxidative enzymes, and protects vitamins C and E. Its anti-inflammatory activity involves reducing inflammatory markers and modulating immune responses. It enhances endothelial nitric oxide synthase activity, leading to vasodilation and improved blood vessel function. Components like taxifolin, catechin, and ferulic acid are rapidly absorbed and excreted, while procyanidins are slowly absorbed and metabolized. By interacting with the cardiovascular and immune systems, it improves endothelial function, reduces blood pressure, and exhibits immunomodulatory effects.

Side effects

French maritime pine bark extract is generally considered safe with low acute and chronic toxicity. The most commonly reported side effects are mild gastrointestinal disturbances, occurring in a small percentage of users. No significant or rare side effects have been consistently documented in the literature. While no significant drug interactions have been reported, caution is advised when using it with anticoagulants due to its antiplatelet effects. It is not specifically contraindicated, but pregnant or breastfeeding women should use it under medical supervision due to limited data. Caution is also advised in patients with bleeding disorders or those taking anticoagulant medications. Overall, it has a favorable safety profile when used as directed.

Dosage

The minimum effective dose of French maritime pine bark extract typically ranges from 50 to 200 mg per day, depending on the specific health condition. Most studies utilize doses between 100 to 200 mg per day. While there is no established maximum safe dose, doses above 200 mg per day are less commonly studied. It is generally taken once or twice daily, without specific timing recommendations. Available in capsule or tablet form, its absorption may be slightly enhanced with food, though not strictly necessary. No specific cofactors are required for its efficacy. Consistency in dosing is recommended to achieve optimal results.

FAQs

Is French maritime pine bark extract safe?

It is generally safe, but individuals with bleeding disorders or those on anticoagulant medications should use it under medical supervision.

When should I take it?

It can be taken at any time of day, but consistency in dosing is recommended for optimal results.

How long before I see results?

Benefits can be expected within a few weeks to months, depending on the specific health condition being addressed.

Is it a cure-all?

No, it is not a cure-all and should be used as part of a comprehensive health plan, including a balanced diet and regular exercise.

Research Sources

  • https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1389374/full – This article discusses the health benefits of Pycnogenol, focusing on its role in cardiovascular health, chronic venous insufficiency, cognition, and other health domains. It highlights the specificity of Pycnogenol and the lack of generalizability to other pine bark extracts, emphasizing the high-quality evidence from numerous randomized double-blind, placebo-controlled trials.
  • https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008294.pub4/information – This Cochrane systematic review assesses the effectiveness and safety of Pycnogenol for treating chronic venous insufficiency. The review analyzes data from multiple randomized controlled trials to determine the impact of Pycnogenol on symptoms and venous function, providing a comprehensive evaluation of its clinical efficacy.
  • https://pubmed.ncbi.nlm.nih.gov/11996210/ – This review examines the pharmacological properties of Pycnogenol, including its antioxidant, anti-inflammatory, and endothelial protective effects. It provides a comprehensive overview of Pycnogenol’s mechanisms of action and its potential therapeutic applications based on both published and unpublished data.
  • https://pubmed.ncbi.nlm.nih.gov/24346156/ – This meta-analysis evaluates the effects of Pycnogenol on lipid profile parameters. Analyzing data from seven trials with 442 patients, the study finds no significant effect of Pycnogenol on fasting lipid profile parameters, with inconsistent findings across trials and no clear dose-effect association except for LDL-C.
  • https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00570545/related-content – This Cochrane review investigates the effects of Pycnogenol on ADHD. The review analyzes data from multiple randomized controlled trials to determine the impact of Pycnogenol on ADHD symptoms, providing a comprehensive evaluation of its clinical efficacy.